课题基金 / 基金详情

Morphological and functional neuroimaging studies on progressive changes in schizophrenia.

Morphological and functional neuroimaging studies on progressive changes in schizophrenia.
关于精神分裂症进行性变化的形态学和功能神经影像学研究。
批准号:
15390348
负责人:
OKUBO Yoshiro
金额:
$8.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2006

项目摘要

项目成果

OKUBO Yoshiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Using both morphological and functional neuroimaging techniques, we aimed to elucidate the progressive changes in the brain of patients with schizophrenia. One hundred twenty patients with schizophrenia aged 20 to 49 years, 60 males and 60 females, and 120 age and gender matched healthy controls were examined by magnetic resonance imaging(MRI). Voxel-based morphometry revealed that age-related decline in the brain morphology was larger in the patient group than in the control groups. This indicates the existence of progressive neuropathology in schizophrenia. Further, the difference in the brain morphology between the patient group and the control group were more prominent in male than in female. Thus, future research should take gender difference into account. Positron emission tomography with [11C[DAA1106 makes it possible to evaluate peripheral benzodiazepine receptors which reflect activated microglia and gliosis in the living human brain. We conducted [11C[DAA1106 PET study in a preliminary sample of patients with schizophrenia and controls. However, there was no statistical difference between groups.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
Language Processing and Human Voice Perception in Schizophrenia : An fMRI study
精神分裂症的语言处理和人类声音感知:一项功能磁共振成像研究
DOI: --
发表时间: 2006
期刊: Biol Psychiatry 59・10
影响因子: --
作者: [Koeda M, Takahashi H, Yahata N, Matsuura M, Asai K, Okubo Y, Tanaka H]
通讯作者: Tanaka H
[11C]PE21 : a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
[11C]PE21:一种高选择性放射性配体,用于猴和人脑中多巴胺转运蛋白的 PET 检查
DOI: --
发表时间: 2003
期刊: Eur J Nucl Med Mol Imaging 30
影响因子: --
作者: [Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, et al.]
通讯作者: et al.
DOI: 10.1016/j.neuroimage.2006.05.049
发表时间: 2006-09
期刊: NeuroImage
影响因子: 5.7
作者: [Hidehiko Takahashi;M. Matsuura;N. Yahata;M. Koeda;T. Suhara;Y. Okubo]
通讯作者: Hidehiko Takahashi;M. Matsuura;N. Yahata;M. Koeda;T. Suhara;Y. Okubo
Abnormal inter-regional relation of dopamine D2 receptor binding in schizophrenia.
精神分裂症中多巴胺 D2 受体结合的异常区域间关系。
DOI: --
发表时间: 2005
期刊: Psychiatry Res 138
影响因子: --
作者: [Takada Y., Kohno R., Himukai T., Kamimura S., Ishibashi K., Kanai T, Keiichiro Inui, Yasuno F.et al.]
通讯作者: Yasuno F.et al.
35
    Brain functional imaging study of possible effects of substance Preceptor antagonist on alcohol craving
    • 批准号:
      22659212
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.1万
    • 财政年份:
      2010
    • 负责人:
      OKUBO Yoshiro
    • 依托单位:
    Molecular imaging of altered dopamine transmission in patients with schizophrenia
    • 批准号:
      19390308
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2007
    • 负责人:
      OKUBO Yoshiro
    • 依托单位:
    PET study of 5-HT1A and GABA receptors in temporal lobe epilepsy.
    • 批准号:
      13670988
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      OKUBO Yoshiro
    • 依托单位:
    Development of three-dimensional atlas of neural transmission and its application for new psychotropic medication
    • 批准号:
      11557070
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      1999
    • 负责人:
      OKUBO Yoshiro
    • 依托单位:
    国内基金
    海外基金
    间位芳纶(PMIA)短切纤维-涤纶(PET)浆粕复合纸的制备设备研发
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      许红伍
    • 依托单位:
    基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
    • 批准号:
      2026JJ81876
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      戴嘉舜
    • 依托单位:
    基于高灵敏度PET/CT的碳离子放疗剂量验证与疗效预测研究
    PET分子影像评估肾癌碳酸酐酶9表达异质性及其对靶免联合治疗响应的预测作用与机制研究
    • 批准号:
      JCZRLH202600197
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: